Octagon's ViewPoint Supports EU Module 1 Specification
Octagon Research Solutions announced support for recent European Union requirements for electronic Common Technical Document (eCTD) Submissions with the general availability of the following new versions of its eCTD product suite:
- ViewPoint v.3.12.0
- Octagon’s eCTD Viewer, v.2.6.0
- Octagon’s eCTD Validator, v.2.6.0
A key feature of the new releases includes support across all three products for eCTD EU Module 1 Specification, version 1.4.
The new product releases include support for updated attributes, naming conventions and checksum information as detailed in the 1.4 specification. The European Union applies the eCTD Specification in the European region as defined by the ICH M2 Working Group and completes it with the EU Module 1 specification.
“Support for the latest EU specification is critical to Octagon’s global clients who are submitting eCTD applications in the European Union,” noted Kirk Gallion, president, Octagon Research Solutions, Inc. “We are committed to supporting these updates as the industry continues to realize the global benefits of electronic submissions in general and the eCTD in particular.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
